Prestige Consumer Healthcare (PBH) Acquisitions (2014 - 2022)
Prestige Consumer Healthcare (PBH) recorded quarterly Acquisitions of $132000.0 in Q1 2022, down 99.27% quarter-over-quarter from $18.0 million in Q4 2021.
Prestige Consumer Healthcare (PBH) Acquisitions (2014 - 2022) Analysis & Trends
Prestige Consumer Healthcare's Acquisitions history runs 5 years deep, the most recent figure standing at $132000.0 for Q1 2022.
- In Q1 2022, Acquisitions changed N/A year-over-year to $132000.0; the TTM figure through Mar 2023 stood at $18.1 million (changed 0.0% YoY), while the FY2022 annual figure was $247.0 million, changed N/A from the prior year.
- Acquisitions was $132000.0 for Q1 2022 at Prestige Consumer Healthcare, down from $18.0 million in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $18.0 million in Q4 2021 to a low of $132000.0 in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.09 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 137.87 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 132,000.00 |
| Dec 31, 2021 | 18.00 Mn |
| Jun 30, 2017 | 970,000.00 |
| Dec 31, 2016 | 1.40 Mn |
| Dec 31, 2014 | -77.99 Mn |
| Jun 30, 2014 | 77.99 Mn |